STAT

JUNE 29, 2024

The Food and Drug Administration’s power to make important regulatory decisions is in question after a Supreme Court decision weakening agencies ’ ability to interpret ambiguous statutory measures. The ruling could mean headaches not just for the teams of lawyers and scientists at the FDA, but for the drug and device companies the agency is charged with regulating.

FDA 132

FDA 132

Drug Topics

JUNE 29, 2024

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

150

150

STAT

JUNE 29, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

FDA 111

FDA 111

Pharmacy Times

JUNE 29, 2024

The European Union (EU) has successfully created a competitive market for biosimilars, while the US faces challenging market dynamics and tactics by pharmacy benefit managers that hinder the adoption of lower-cost therapies.

50

50

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Checkup by Singlecare

JUNE 29, 2024

Polycystic ovary syndrome (PCOS) is a complex, often frustrating condition that causes a hormonal imbalance—typically an increase in androgens , or male sex hormones, which are any hormone capable of developing and maintaining masculine characteristics in reproductive tissues. Testosterone, for example, is an androgen. Women with PCOS experience irregular periods and difficulty losing weight due to insulin resistance.

Insurance 52

Insurance Dosage FDA Labelling 52